Melanoma of the lower female genital tract (vulva, vagina, and cervix): literature review and own cases
https://doi.org/10.17650/1994-4098-2019-15-3-44-53
Abstract
The article covers various aspects of clinical manifestations, diagnosis, and treatment of vulvar, vaginal, and cervical melanomas.
About the Authors
K. V. Safronova
N.N. Petrov National Medical Research Center of Onclology, Ministry of Health of Russia; I.I. Mechnikov North-Western State Medical University, Ministry of Health of Russia
Russian Federation
Competing Interests: not
Russian Federation
68 Leningradskaya St., Pesochnyi Settlement, Saint Petersburg 197758; 41 Kirochnaya St., Saint Petersburg 191015
Competing Interests: not
A. S. Artemyeva
N.N. Petrov National Medical Research Center of Onclology, Ministry of Health of Russia
Russian Federation
Competing Interests: not
Russian Federation
68 Leningradskaya St., Pesochnyi Settlement, Saint Petersburg 197758
Competing Interests: not
A. A. Sidoruk
N.N. Petrov National Medical Research Center of Onclology, Ministry of Health of Russia
Russian Federation
Competing Interests: not
Russian Federation
68 Leningradskaya St., Pesochnyi Settlement, Saint Petersburg 197758
Competing Interests: not
D. A. Chuglova
N.N. Petrov National Medical Research Center of Onclology, Ministry of Health of Russia
Russian Federation
Competing Interests: not
Russian Federation
68 Leningradskaya St., Pesochnyi Settlement, Saint Petersburg 197758
Competing Interests: not
K. E. Khidishyan
N.N. Petrov National Medical Research Center of Onclology, Ministry of Health of Russia
Russian Federation
Competing Interests: not
Russian Federation
68 Leningradskaya St., Pesochnyi Settlement, Saint Petersburg 197758
Competing Interests: not
N. A. Mikaya
N.N. Petrov National Medical Research Center of Onclology, Ministry of Health of Russia
Russian Federation
Competing Interests: not
Russian Federation
68 Leningradskaya St., Pesochnyi Settlement, Saint Petersburg 197758
Competing Interests: not
I. V. Berlev
N.N. Petrov National Medical Research Center of Onclology, Ministry of Health of Russia; I.I. Mechnikov North-Western State Medical University, Ministry of Health of Russia
Russian Federation
Competing Interests: not
Russian Federation
68 Leningradskaya St., Pesochnyi Settlement, Saint Petersburg 197758; 41 Kirochnaya St., Saint Petersburg 191015
Competing Interests: not
A. F. Urmancheeva
N.N. Petrov National Medical Research Center of Onclology, Ministry of Health of Russia; I.I. Mechnikov North-Western State Medical University, Ministry of Health of Russia
Russian Federation
Competing Interests: not
Russian Federation
68 Leningradskaya St., Pesochnyi Settlement, Saint Petersburg 197758; 41 Kirochnaya St., Saint Petersburg 191015
Competing Interests: not
E. A. Ulrikh
N.N. Petrov National Medical Research Center of Onclology, Ministry of Health of Russia; I.I. Mechnikov North-Western State Medical University, Ministry of Health of Russia
Russian Federation
Competing Interests: not
Russian Federation
68 Leningradskaya St., Pesochnyi Settlement, Saint Petersburg 197758; 41 Kirochnaya St., Saint Petersburg 191015
Competing Interests: not
References
1. Tacastacas J.D., Bray J., Cohen Y.K. et al. Update on primary mucosal melanoma. J Am Acad Dermatol 2014;71 (2):366—75.
2. Creasman W.T., Phillips J.L., Menck H.R. A survey of hospital management practices for vulvar melanoma. J Am Coll Surg 1999;188:670-5.
3. Stang A., Streller B., Eisinger B. et al. Population-based incidence rates of malignant melanoma of the vulva in Germany. Gynecol Oncol 2005;96:216-21.
4. Chang A.E., Karnell L.H., Menck H.R. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 1998;83:1664-78.
5. Vyas R., Thompson C., Zargar H. et al. Epidemiology of genitourinary melanoma in the United States: 1992 through 2012. J Am Acad Dermatol 2016;75 (1):144—50.
6. Hu D.N., Yu G.P., McCormick S.A. Population-based incidence of vulvar and vaginal melanoma in various races and ethnic groups with comparisons to other site-specific melanomas. Melanoma Res 2010;20:153-8.
7. Stang A., Streller B., Eisinger B. et al. Population-based incidence rates of malignant melanoma of the vulva in Germany. Gynecol Oncol 2005;96:216-21.
8. Sugiyama V.E., Chan J.K., Shin J.Y. et al. Vulvar melanoma: a multivariable analysis of 644 patients. Obstet Gynecol 2007:110:296-301.
9. Aulmann S., Sinn H.P., Penzel R. et al. Comparison of molecular abnormalities in vulvar and vaginal melanomas. Mod Pathol 2014:27:1386-93.
10. Ragnarsson-Olding B., Johansson H., Rutqvist L.E. et al. Malignant melanoma of the vulva and vagina. Trends in incidence, age distribution, and long-term survival among 245 consecutive cases in Sweden 1960-1984. Cancer 1993;71:1893-7.
11. Gökaslan H., Sişmanoğlu A., Pekin T. et al. Primary malignant melanoma of the vagina: a case report and review of the current treatment options. Eur J Obstet Gynecol Reprod Biol 2005;121:243-8.
12. Kalampokas E., Kalampokas T., Damaskos C. Primary vaginal melanoma, a rare and aggressive entity. A case report and review of the literature. In Vivo 2017:31:133-9.
13. Frumovitz M., Etchepareborda M., Sun C.C. et al. Primary malignant melanoma of the vagina. Obstet Gynecol 2010;116:1358-65.
14. Pusceddu S., Bajetta E., Carcangiu M.L. et al. A literature overview of primary cervical malignant melanoma: an exceedingly rare cancer. Crit Rev Oncol Hematol 2012;81:185-95.
15. Bishop K.D., Olszewski A.J. Epidemiology and survival outcomes of ocular and mucosal melanomas: a population-based analysis. Int J Cancer 2014;134:2961-71.
16. Pleunis N., Schuurman M.S., Van Rossum M.M. et al. Rare vulvar malignancies; incidence, treatment and survival in the Netherlands. Gynecol Oncol 2016;142:440-5.
17. Verschraegen C.F., Benjapibal M., Supakarapongkul W. et al. Vulvar melanoma at the M.D. Anderson Cancer center: 25 years later. Int J Gynecol Cancer 2011;11:359-64.
18. Seifried S., Haydu L.E., Quinn M.J. et al. Melanoma of the vulva and vagina: principles of staging and their relevance to management based on a clinicopatho-logic analysis of 85 cases. Ann Surg Oncol 2015;22:1959-66.
19. Look K. Y., Roth L.M., Sutton G.P. Vulvar melanoma reconsidered. Cancer 1993;72:143-6.
20. Trimble E. L., Lewis J.L., Williams L.L. et al. Management of vulvar melanoma. Gynecol Oncol 1992;45:254-25.
21. Kirschner A.N., Kidd E.A., Dewees T., Perkins S.M. Treatment approach and outcomes of vaginal melanoma. Cancer 2013;23:1484-9.
22. Huang Q., Huang H., Wan T. et al. Clinical outcome of 31 patients with primary malignant melanoma of the vagina. J Gynecol Oncol 2013;24:330-5.
23. Buchanan D.J., Schlaerth J., Kurosaki T. Primary vaginal melanoma: thirteenyear disease-free survival after wide local excision and review of recent literature. Am J Obstet Gynecol 1998;178:1177-84.
24. Clark K.C., Butz W.R., Hapke M.R. Primary malignant melanoma of the uterine cervix: case report with world literature review. Int J Gynecol Pathol 1999;18:265-73.
25. Cantuaria G., Angioli R., Fernandez-Abril A., Penalver M. Primary malignant melanoma of the uterine cervix: case report and review of the literature. Prim Care Update Ob Gyns 1998;5:159-60.
26. Rohwedder A., Philips B., Malfetano J. et al. Vulvar malignant melanoma associated with human papillomavirus DNA: report of two cases and review of literature. Am J Dermatopathol 2002;24:230-40.
27. Omholt K., Grafstrom E., Kanter Lewensohn L. KIT pathway alterations in mucosal melanomas of the vulva and other sites. Clin Cancer Res 2001;17:3933-42.
28. Aulmann S., Sinn H.P., Penzel R. et al. Comparison of molecular abnormalities in vulvar and vaginal melanomas. Mod Pathol 2014;27:1386-93.
29. Mordel N., Mor-Yosef S., Ben-Baruch N., Anteby S.O. Malignant melanoma of the uterine cervix: case report and review of the literature. Gynecol Oncol 1989;32:375-80.
30. An J., Li B., Wu L. et al. Primary malignant amelanotic melanoma of the female genital tract: report of two cases and review of literature. Melanoma Res 2009;19:267-70.
31. Noguchi T., Ota N., Mabuchi Y. et al. A case of malignant melanoma of the uterine cervix with disseminated metastases throughout the vaginal wall. Case Rep Obstet Gynecol 2017: (2017):5656340.
32. Norris H.J., Taylor H.B. Melanomas of the vagina. Am J Clin Pathol 1966;46:420-6.
33. Gleason B.G., Hirsch M.N., Nucci M.R. et al. Atypical genital nevi. A clinicopathologic analysis of 56 cases. Am J Surg Pathol 2008;32:51-7.
34. Hou J.Y., Baptiste C., Hombalegowda R.B. et al. Vulvar and vaginal melanoma: a unique subclass of mucosal melanoma based on a comprehensive molecular analysis of 51 cases compared with 2253 cases of nongynecologic melanoma. Cancer 2017;123:1333-44.
35. Sugiyama V.E., Chan J.K., Kapp D.S. Management of melanomas of the female genital tract. Curr Opin Oncol 2008;20:565-9.
36. Leitao Jr.M.M. Management of vulvar and vaginal melanomas: current and future strategies. Am Soc Clin Oncol Educ Book 2014:e277-81.
37. Karasawa K., Wakatsuki M., Kato S. et al. Working Group for Gynecological Tumors. Clinical trial of carbon ion radiotherapy for gynecological melanoma. J Radiat Res 2014;55:343-50.
38. Leitao Jr.M.M., Cheng X., Hamilton A.L. et al. Gynecologic Cancer Inter Group (GCIG) consensus review for vulvovaginal melanomas. Int J Gynecol Cancer 2014;24 (9 Suppl 3):S117—22.
39. Janco J.M., Markovic S.N., Weaver A.L. et al. Vulvar and vaginal melanoma: case series and review of current management options including neoadjuvant chemotherapy. Gynecol Oncol 2013;129:533-7.
40. Sinasac S.E., Petrella T.M., Rouzbah-man M. et al. Melanoma of the vulva and vagina: surgical management and outcomes based on a clinicopathologic review of 68 cases. J Obstet Gynaecol Can 2019;41(6):762-71.
41. Gadducci A., Carinelli S., Guerri-eri M.E., Aletti G.D. Melanoma of the lower genital tract: Prognostic factors and treatment modalities. Gynecol Oncol 2018;150(1):180-9.
42. Danish H.H., Patel K.R., Switchenko J.M. et al. The influence of postoperative lymph node radiation therapy on overall survival of patients with stage III melanoma, a National Cancer Database analysis. Melanoma Res 2016;26:595-603.
43. Slingluff C.L., Flaherty K., Posenberg S. A. et al. Cutaneous melanoma. In: Cancer: Principles and practice of oncology. 9th edn. Eds.: V. T. DeVita, T. S. Lawrence, S.A. Rosenberg. Philadelphia: Lippincott Williams & Wilkins, 2011. Pp. 1643-1691.
44. Piura B. Management of primary melanoma of the female urogenital tract. Lancet Oncol 2008;9:973-81.
45. Wilson M.A., Schuchter L.M. Chemotherapy for melanoma. Cancer Treat Res 2016;167:209-29.
46. Harting M.S., Kim K.B. Biochemotherapy in patients with advanced vulvovaginal mucosal melanoma. Melanoma Res 2004; 14:517-20.
47. Volpe V.O., Klufas D.M., Hegde U. The new paradigm of systemic therapies for metastatic melanoma. J Am Acad Dermatol 2017;77:356-68.
48. Chapman P.B., Hauschild A., Robert C. et al. BRIM-3 Study Group, Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med 2011;364:2507-16.
Review
For citations:
Safronova K.V., Artemyeva A.S., Sidoruk A.A., Chuglova D.A., Khidishyan K.E., Mikaya N.A., Berlev I.V., Urmancheeva A.F., Ulrikh E.A. Melanoma of the lower female genital tract (vulva, vagina, and cervix): literature review and own cases. Tumors of female reproductive system. 2019;15(3):44-53. (In Russ.) https://doi.org/10.17650/1994-4098-2019-15-3-44-53
Views:
830
Email this article 